IMPACT Audit
@IMPACTaudit
Followers
501
Following
286
Media
13
Statuses
215
The IMPACT Audit aims to improve standards in MDT management of patients with locally advanced and recurrent rectal cancer in the UK. @ACPGBI. Funded by @BDRF.
Joined March 2019
📣 IMPACT Collaboration Meeting ⭐️, Monday 5th September 2022, RCS England, London. Come along for an update on the IMPACT programme as well as current research and developments in advanced colorectal cancer. Programme announced very soon. Register here: https://t.co/f3L4IByPXw
0
5
12
Devastated to hear @bowelbabe news. She’s dedicated the last 5 years to advocating for bowel cancer patients. We were incredibly grateful to her for attending our original IMPACT day in 2017. A huge inspiration. @CR_UK @bowelcanceruk @royalmarsden
justgiving.com
Please support the Bowelbabe Fund for Cancer Research UK, raising money to fund clinical trials, research and cancer information and awareness, as well as other initiatives to combat cancer and...
0
3
7
LRRC-QoL Study December 2021 Newsletter 1️⃣2️⃣4️⃣ patients recruited! Thank you to our collaborators and all the patients who have participated in the study so far! Wishing you a Merry Christmas and Happy New Year!
2
10
19
November Newsletter for the LRRC-QoL study! 1️⃣1️⃣6️⃣ patients recruited! 1/3 of the way there with recruitment to workstreams I & II! #LRRCQoL #PROMs #collaborativeresearch #QoL
3
13
30
Excited for 🇬🇧🇫🇷🚀collab in my new role Cons CR Surgeon @MFTnhs with a brilliant,dynamic & supportive team @SarahDuff3 @MissLHancock @TelfordKaren999 @walbaraza @nickstylianides @KatyNewton17 @JamesHill1010 @Ben_Hornung @chriscraigCCC, @StellaSmithSurg Ramesh,Abi,Finlay & Dave
35
16
142
⭐️ IMPROVING PATIENT EXPERIENCE --> END OF LIFE LOCAL QI 🎯 ✨ >95% referral to palliative care in last year of life ✨ <20% patients receiving palliative systemic tx in last 30d of life @ACPGBI @BCI_UK @IanJackson50 @VBlush @IMPACTaudit @pelican_cancer
#NBOCAQualityImp
1
5
7
⭐️ IMPROVING CANCER OUTCOMES --> STAGE IV DISEASE LOCAL QI 🎯 ✨ >95% with liver mets discussed in specialist MDT ✨ >80% stage IV patients w/ genetic profiling (KRAS, BRAF) @ACPGBI @ColorectalDis @DeenaHarji @IMPACTaudit @AbigailVallance @StMarksHospital
#NBOCAQualityImp
1
5
5
A7b. @NBOCA_CEU now collects genomic profiling data (RAS/BRAF) to ensure targeted & personalised systemic treatments in patients with stage IV disease #IMPACTimoact. Even MMR status makes a difference to treatment options in patients with stage IV disease. #NBOCAQualityImp
0
9
15
Being assigned to a CNS is associated with better experiences of cancer care; new findings from the analysis of the CPES & cancer registry dataset ref Alessy et al 2021 EJON #CNSvalue #carecoordination #personalisedcare #patientinvolvement
3
43
136
Hear the latest updates on the management of PMP at #PSOGI2021 Session on PMP (Sept 12, 2021, Sunday) https://t.co/Qit0wy53Q8
@BasingstokePmi @acpmpresearch @europmp @PMPSurvivor @SPeritoneum @APeritoneum @sam_meso @meso_sheffield @eurordis @RareDiseases
'It's a Tuesday morning in @BasingstokePmi ,' #FaheezMohamed @FaheezM from the OR 'Hear the latest udates on PMP from the Basingstoke group @FaheezM @Brendan92855812 @TomCecilMD #normancarr who will all be online #PSOGI2021 Good opportunity to share ideas' @acpmpresearch
0
7
18
Pathology reporting of pelvic exenteration specimens for locally recurrent rectal cancer @SilvioDaester @SofronisL @RACSurgeons @CSSANZ2
@SOuRCe_RPA @RPA_IAS @PelvExGroup @ESSOnews @ESP_Pathology @PathologyRCPA @RCPath
@HelenMohan1 @DeenaHarji @3isac
https://t.co/Fy0g0u4OsH
0
16
25
📣August updates from the LRRC-QoL study: 2️⃣3️⃣ sites open to recruitment in 1️⃣1️⃣ countries. 6️⃣2️⃣ patients recruited 🎉 Study website now live: https://t.co/Pcv1EH3ECG
2
13
20
Virtual MRI for colorectal surgeons - Free webinar for @Dukes_Club @ACPGBI members. Part 1: Normal anatomy and staging rectal cancer w/ @AliCorr1 @bengriffiths73 @HelenMohan1 @MrJTJenkins @AmyLord1 @Jordanfletch6 14/9/21 8pm https://t.co/2QUgpMuAS6
2
39
49
Great review on compartment wise exenterative procedures for LARC/LRRC by #teamcolorectal @TataMemorial
@QDenost @DeenaHarji @ACPGBI @somusp9 @SWexner @Shrikhande_SV @MrJTJenkins @drajitpai @Manishbhandare4 @hbchsangrur @TMC_Varanasi @DrAmitDangi
Happy to share our review on compartment wise approach to recurrent and advanced cancers. https://t.co/3T42UcQwef
@TataMemorial @LAOS1860 @escp_tweets @YouESCP @jeetrohila @docswapnil01 @vivekanandkem
1
8
14
Huge congratulations to Anwen Williams on receiving her 1️⃣st research grant 👏🏽👏🏽👏🏽 Thanks @BowelResearch for the support #proudPhDsupervisor @SwanseaCRECT @evanscolorectal @deanharris81 Looking forward to continuing this work with @NatsWoodward @claire_taylor22 @DeeGeeee
2
12
47
Shared decision making starts with patient understanding. In our 3DCC study we're evaluating if personalised 3D models derived scan data can help CC patients understand their disease and treatment options to make an informed choice @DaniloMisko @MrJTJenkins @EMBurns2017 #3DCC
3
15
59
Pushing recovery in pelvic exenteration - démonstrating #ERAS is feasible in complex settings. ⬆️ adhérence = ⬇️ complications & LoS. Next steps = QoL & Qual of Recovery data @ErasSociety @CHUBordeaux @QDenost @GregoireRob @Brardxavier1 @PelvExGroup @UKPEN__ @IMPACTaudit
IN PRESS The feasibility of implementing an enhanced recovery programme in patients undergoing pelvic exenteration @DeenaHarji @QDenost @CHUBordeaux
@ESSOnews @ACPGBI @me4_so @debby_keller @3isac @HelenMohan1 @MISIRG1 @Cirbosque @YouESCP @juliomayol
https://t.co/Il5LGl3U41
1
16
28
IN PRESS The feasibility of implementing an enhanced recovery programme in patients undergoing pelvic exenteration @DeenaHarji @QDenost @CHUBordeaux
@ESSOnews @ACPGBI @me4_so @debby_keller @3isac @HelenMohan1 @MISIRG1 @Cirbosque @YouESCP @juliomayol
https://t.co/Il5LGl3U41
1
16
29
Delighted to be a part of 👇🏽 work. Much more exciting work yet to come from @RebMuiCab @OcathailS @greccar @QDenost @C_Roxburgh @PeterCh97444486 @claire_taylor22 on reirradiation in locally recurrent rectal cancer @PelvExGroup @UKPEN__ @IMPACTaudit
SBRT reirradiation for locally recurrent rectal cancer ▪️ retrospective multicenter study (n=69) ▪️ mostly lateral LN mets ▪️ 30Gy / 5Fx ☑️ 42.6% local relapse ☑️ 58.3% of deaths attributed to local relapse 👉 higher SBRT dose? surgery if possible? #radonc
https://t.co/qSpCHBfT2e
1
4
7